{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:10:03Z","timestamp":1787314203797,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Foundation of Guangzhou City of China","award":["2015010090"],"award-info":[{"award-number":["2015010090"]}]},{"name":"Major Scientific Research Foundation of Colleges and Universities of Guangdong Provience","award":["2016KZDXM016"],"award-info":[{"award-number":["2016KZDXM016"]}]},{"name":"Clinical Training Foundation of Southern Medical University","award":["LC2016PY002"],"award-info":[{"award-number":["LC2016PY002"]}]},{"name":"Innovative Foundation of Guangdong Province of China","award":["2014KZDXM020"],"award-info":[{"award-number":["2014KZDXM020"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.molimm.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T17:01:27Z","timestamp":1547139687000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["ZAP70 deficiency promotes reverse cholesterol transport through MAPK\/ERK pathway in Jurkat cell"],"prefix":"10.1016","volume":"107","author":[{"given":"Jichen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.01.001_bib0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.2008.00753.x","article-title":"The structure, regulation, and function of ZAP-70","volume":"228","author":"Au-Yeung","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molimm.2019.01.001_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"Back","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","article-title":"HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target","volume":"18","author":"Bhatt","year":"2016","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.molimm.2019.01.001_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI119681","article-title":"The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-\/- mice","volume":"100","author":"Daugherty","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2019.01.001_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-09665-0_4","article-title":"Cholesterol efflux and reverse cholesterol transport","volume":"224","author":"Favari","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fimmu.2016.00255","article-title":"Dynamic regulation of TCR-microclusters and the microsynapse for T cell activation","volume":"7","author":"Hashimoto-Tane","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biopha.2018.03.082","article-title":"Silencing ZAP70 prevents HSP65-induced reverse cholesterol transport and NF-kappaB activation in T cells","volume":"102","author":"Hu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molimm.2019.01.001_bib0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MOL.0000000000000209","article-title":"Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL","volume":"26","author":"Hutchins","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.01.001_bib0050","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.4049\/jimmunol.1502710","article-title":"Lck inhibits heat shock protein 65-Mediated reverse cholesterol transport in t cells","volume":"197","author":"Luo","year":"2016","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.molimm.2019.01.001_bib0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.plipres.2011.04.002","article-title":"Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy","volume":"50","author":"McLaren","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.molimm.2019.01.001_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.molimm.2019.01.001_bib0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/376435a0","article-title":"Essential role for ZAP-70 in both positive and negative selection of thymocytes","volume":"376","author":"Negishi","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2019.01.001_bib0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2006.06.007","article-title":"A CD36-dependent signaling cascade is necessary for macrophage foam cell formation","volume":"4","author":"Rahaman","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.molimm.2019.01.001_bib0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.01.001_bib0080","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.01.001_bib0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molimm.2019.01.001_bib0090","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1194\/jlr.M500080-JLR200","article-title":"The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver","volume":"46","author":"Sabol","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molimm.2019.01.001_bib0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00395-009-0072-9","article-title":"Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression","volume":"105","author":"Seeger","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","article-title":"Monocyte-macrophages and t cells in atherosclerosis","volume":"47","author":"Tabas","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2019.01.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002279","article-title":"ZAP-70: an essential kinase in T-cell signaling","volume":"2","author":"Wang","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molimm.2019.01.001_bib0110","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/annrheumdis-2013-203759","article-title":"Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-\/- mice","volume":"74","author":"Wilhelm","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2019.01.001_bib0115","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2015.4697","article-title":"Inhibition of ERK1\/2 improves lipid balance in rat macrophages via ABCA1\/G1 and CD36","volume":"13","author":"Xue","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.molimm.2019.01.001_bib0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.molimm.2019.01.001_bib0125","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbalip.2016.06.017","article-title":"MEK1\/2 inhibitors activate macrophage ABCG1 expression and reverse cholesterol transport-an anti-atherogenic function of ERK1\/2 inhibition","volume":"1861","author":"Zhang","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2019.01.001_bib0130","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1161\/01.CIR.102.24.2919","article-title":"Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice","volume":"102","author":"Zhou","year":"2000","journal-title":"Circulation"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019300033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019300033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T14:29:02Z","timestamp":1551796142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019300033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":26,"alternative-id":["S0161589019300033"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.01.001","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZAP70 deficiency promotes reverse cholesterol transport through MAPK\/ERK pathway in Jurkat cell","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}